News

TTY Biopharm has signed an agreement with to-BBB for the manufacturing of brain-targeted doxorubicin liposomes. These liposomes are essential for the clinical development of to-BBB’s lead product for

inPharmative has completed the implementation of its pharmaceutical rebate management technology solution for Blue Cross Blue Shield of Arizona. inPharmative provides rebate management technology solutions through web-based decision

Pfizer has collaborated with Private Access to create a new online community aimed at increasing clinical trial awareness and participation. The site will focus on patient privacy rights

International Oncology Network (ION) has entered into an agreement with Altos Solutions that gives access to OncoEMR, Altos Solutions’ electronic medical records (EMR) system. The company claims that

OmniComm has reported that Impax has selected its TrialMaster EDC solution for conducting a phase III study in patients with Parkinson’s Disease. Impax would use OmniComm’s TrialMaster EDC

Smith & Nephew Biologics & Spine is proceeding to the next stage in the approval process for the US launch of DUROLANE Single Injection, Stabilized Hyaluronic Acid. ADVERTISEMENT

During the second quarter of 2009, Sinovac has reported sales of $20.2m, an increase of 21.2% from $16.5m in the second quarter of 2008. The gross profit for

Holzer Holzer & Fistel, has filed a class action lawsuit in the US District Court for the District of Massachusetts on behalf of purchasers of Genzyme Corporation, who

InterMed Discovery (IMD) has reported the acquisition of microbial Omega-3 fatty acid production strains and related know-how from the University of Saarland. Reportedly, the microbial source has the